Abstract
Targeted biologic therapies have revolutionised treatment of immune-mediated inflammatory diseases (IMIDs) due to their efficacy, speed of onset and tolerability. The discovery that clinically unrelated conditions, such as rheumatoid arthritis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have